Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian

NCT05638477 is registered in ClinicalTrials.gov with Conor Fearon as lead sponsor.

NCT NCT05638477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian
Lead sponsor
Conor Fearon
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
August 15, 2024
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corticobasal degeneration, multiple system atrophy, parkinson's disease and parkinsonism, progressive supranuclear palsy